NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Excerpt
Digital breast tomosynthesis (DBT) has rapidly been adopted by many providers of mammography screening in the United States. This report summarizes the evidence published through October 2015 regarding the diagnostic test characteristics of tomosynthesis in screening populations.
Contents
Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services1. Contract No. HHSA-290-2012-00015-I, Task Order No. 5. Prepared by: Center for Healthcare Policy and Research2, Kaiser Permanente Research Affiliates Evidence-based Practice Center3
Suggested citation:
Melnikow J, Fenton JJ, Miglioretti D, Whitlock EP, Weyrich MS. Screening for Breast Cancer With Digital Breast Tomosynthesis. Evidence Synthesis No. 125. AHRQ Publication No. 14-05201-EF-2. Rockville, MD: Agency for Healthcare Research and Quality; 2016.
This report is based on research conducted by the University of California, Davis Center for Healthcare Policy and Research and the Kaiser Permanente Research Affiliates Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (HHSA-290-2012-00015-I, Task Order No. 5). The findings and conclusions in this document are those of the authors, who are responsible for its contents, and do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.
The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Anyone who makes decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information (i.e., in the context of available resources and circumstances presented by individual patients).
This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
This document is in the public domain and may be used and reprinted without permission except those copyrighted materials that are clearly noted in the document. Further reproduction of those copyrighted materials is prohibited without the specific permission of copyright holders.
None of the investigators has any affiliations or financial involvement that conflicts with the material presented in this report.
- 1
5600 Fishers Lane, Rockville, MD 20857; www
.ahrq.gov - 2
University of California, Davis, Sacramento, CA
- 3
Kaiser Permanente Center for Health Research, Portland, OR
- NLM CatalogRelated NLM Catalog Entries
- Review Digital Breast Tomosynthesis with Hologic 3D Mammography Selenia Dimensions System for Use in Breast Cancer Screening: A Single Technology Assessment[ 2017]Review Digital Breast Tomosynthesis with Hologic 3D Mammography Selenia Dimensions System for Use in Breast Cancer Screening: A Single Technology AssessmentMovik E, Dalsbø TK, Fagelund BC, Friberg EG, Håheim LL, Skår Å. 2017 Sep 4
- Digital Mammography versus Digital Mammography Plus Tomosynthesis in Breast Cancer Screening: The Oslo Tomosynthesis Screening Trial.[Radiology. 2019]Digital Mammography versus Digital Mammography Plus Tomosynthesis in Breast Cancer Screening: The Oslo Tomosynthesis Screening Trial.Skaane P, Bandos AI, Niklason LT, Sebuødegård S, Østerås BH, Gullien R, Gur D, Hofvind S. Radiology. 2019 Apr; 291(1):23-30. Epub 2019 Feb 19.
- Radiation exposure and screening yield by digital breast tomosynthesis compared to mammography: results of the TOSYMA Trial breast density related.[Eur Radiol. 2025]Radiation exposure and screening yield by digital breast tomosynthesis compared to mammography: results of the TOSYMA Trial breast density related.Sommer A, Weigel S, Hense HW, Gerß J, Weyer-Elberich V, Kerschke L, Nekolla E, Lenzen H, Heindel W, TOSYMA Screening Trial Study Group. Eur Radiol. 2025 Jan; 35(1):166-176. Epub 2024 Jul 16.
- Discordant and false-negative interpretations at digital breast tomosynthesis in the prospective Oslo Tomosynthesis Screening Trial (OTST) using independent double reading.[Eur Radiol. 2024]Discordant and false-negative interpretations at digital breast tomosynthesis in the prospective Oslo Tomosynthesis Screening Trial (OTST) using independent double reading.Skaane P, Østerås BH, Yanakiev S, Lie T, Eben EB, Gullien R, Brandal SHB. Eur Radiol. 2024 Jun; 34(6):3912-3923. Epub 2023 Nov 8.
- Digital breast tomosynthesis for breast cancer detection: a diagnostic test accuracy systematic review and meta-analysis.[Eur Radiol. 2020]Digital breast tomosynthesis for breast cancer detection: a diagnostic test accuracy systematic review and meta-analysis.Alabousi M, Zha N, Salameh JP, Samoilov L, Sharifabadi AD, Pozdnyakov A, Sadeghirad B, Freitas V, McInnes MDF, Alabousi A. Eur Radiol. 2020 Apr; 30(4):2058-2071. Epub 2020 Jan 3.
- Screening for Breast Cancer With Digital Breast TomosynthesisScreening for Breast Cancer With Digital Breast Tomosynthesis
Your browsing activity is empty.
Activity recording is turned off.
See more...